In Vitro Release Tests (IVRT)
We test drug release in a fast and reliable way using IVRT based on vertical diffusion cells and synthetic membranes.
The release of an active pharmaceutical ingredient (API) from its formulation is highly dependent on the composition of the drug. We use IVRT for formulation optimization, quality control, generic drug approval and to demonstrate product equivalence for post-approval changes.
Our Services
- Development of new IVRT methods for e.g. diclofenac, acyclovir
- Adaptation of existing IVRT methods
- Validation of IVRT methods according to EMA and FDA guidelines
- IVRT trials and product tests according to GLP guidelines
- Development of analytical methods
- Validation of analysis methods according to ICH guidelines
- Sample analysis, clinical data management and statistical evaluation according to GLP guidelines
Research groups
Downloads
Shareholdings & Funding
Das sagen unsere Kunden
More Products and Services
Fast and efficient PK-based bioequivalence studies for topical generics
Unique de-risking and proof-of-mechanism studies for dermal active ingredients
Specialized methods for analyses and testing for preclincial and clinical studies (GLP and non-GLP).
Instruments and methods for the measurement of pharmacokinetics and pharmacodynamics in different tissues.
Comprehensive and compliant data management and biostatistics for clinical trials
We perform untargeted and targeted metabolomics studies to quantify metabolites to investigate metabolic processes and identify biomarkers.
The digital checklist and cross-professional process documentation for surgical procedures.
CDS-BARS module for patient-centered, cross-professional, interdisciplinary collaboration and documentation on acute geriatric wards
We offer extensive, professional support in reporting and publishing the results of your preclinical and clinical studies.
aOFM can be used to monitor local drug distribution and biomarkers in subcutaneous adipose tissue.
